There’s nothing “garden variety” about the salads in the latest cookbook from Michael Rantissi and Kristy Frawley.
Popular Australian singer Don Spencer confirmed the sad news with a heartbreaking tribute on social media. “I am terribly saddened to hear that the beautiful Virginia Lillye has lost her battle with ...
It starts with a variety of unappetising smoothies, or language like "embarrassed" or "guilt". Visible on prime-time TV, radio and social media, the two advertising campaigns are clearly weight ...
Add articles to your saved list and come back to them anytime. This recipe features in the most popular recipes of October 2025 collection. See all stories. Look, I’m not saying I stalk restaurant ...
Alabama football head coach Kalen DeBoer gave an update on running back Jam Miller, who is dealing with a concussion. On Saturday afternoon, the Alabama football program moved to 5-1 on the 2025 ...
Eli Lilly has guided its oral GLP-1 drug candidate orforglipron through two more late-phase tests in Type 2 diabetes, racking up wins against placebo and AstraZeneca’s Farxiga to stay on track to seek ...
A major traffic jam, stretching for several kilometres on Bengaluru's Outer Ring Road (ORR), was caused after a Bengaluru Metropolitan Transport Corporation (BMTC) bus broke down on Tuesday (Oct 14) ...
In this episode of In The Kitchen With Matt, I will show you how to make chocolate Crackles. Chocolate Crackles are a super easy treat to make and are very popular in Australia. They serve them for ...
After beating Novo Nordisk’s semaglutide last month, Lilly’s much anticipated oral candidate orforglipron has taken down AstraZeneca’s Farxiga in a head-to-head trial. Eli Lilly’s oral GLP-1 ...
Eli Lilly released the results of two new Phase 3 trials of an experimental GLP-1 pill that the company says could become a “foundational treatment” for type 2 diabetes. The medicine, orforglipron, ...
Eli Lilly: Was I Too Cautious? We don't get everything right, do we? While I nailed the upgrade in Eli Lilly and Company (NYSE:LLY) stock in my last write-up in August, some of you might contend that ...